Keywords: taro, gains, final, fda, appro, cetirizine, israel-headquartered

Taro gains final FDA appro for cetirizine

Article | 30 June 2008

Israel-headquartered Taro Pharmaceutical Industries, which recently pulled out of a merger deal with India's Sun Pharmaceuticals (Marketletter June 9), says that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in